ResMed Inc.

NYSE:RMD

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

🌐 Software-as-a-Service (SaaS)

💻 Software & Operating Systems

💻 Telehealth

Location

United States

Market Cap

USD 40.68 B

Share Price

USD 277.44

Avg Daily Volume

873,362

Change (1 day)

-0.09%

Change (1 year)

33.36%

Change (YTD)

21.32%

ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.65 B

ResMed Inc. Operating Cash Flow is USD 1.65 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 37.91% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.20 B, a 123.89% change year over year.
ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 535.35 M, a 7.46% change year over year.
ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 498.19 M, a -40.72% change year over year.
ResMed Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 840.46 M, a 36.93% change year over year.